Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wael Sumaya

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Platelets|June 17, 2020
Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary interventionWael Sumaya, William A E Parker, Heather M Judge, et al.
Platelets|July 3, 2025
Differential effects of dual antiplatelet and dual antithrombotic therapy on hemostasis in chronic coronary syndrome patients: the DEFINE CCS studyTony Haddad, Osama Elkhateeb, Lawrence Title, et al.
Platelets|February 14, 2019
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndromeWilliam A E Parker, Rachel C Orme, Jessica Hanson, et al.
Thrombosis and Haemostasis|June 7, 2018
Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study)Wael Sumaya, William A E Parker, Rebekah Fretwell, et al.
Circulation|June 23, 2018
Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery DiseaseRachel C Orme, William A E Parker, Mark R Thomas, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Platelets|June 17, 2020
Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary interventionWael Sumaya, William A E Parker, Heather M Judge, et al.
Platelets|July 3, 2025
Differential effects of dual antiplatelet and dual antithrombotic therapy on hemostasis in chronic coronary syndrome patients: the DEFINE CCS studyTony Haddad, Osama Elkhateeb, Lawrence Title, et al.
Platelets|February 14, 2019
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndromeWilliam A E Parker, Rachel C Orme, Jessica Hanson, et al.
Thrombosis and Haemostasis|June 7, 2018
Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study)Wael Sumaya, William A E Parker, Rebekah Fretwell, et al.
Circulation|June 23, 2018
Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery DiseaseRachel C Orme, William A E Parker, Mark R Thomas, et al.
Pageof 2